Thyroid Hormones and Thyromimetics: A New Approach to Nonalcoholic Steatohepatitis?
- PMID: 32104916
- PMCID: PMC7496265
- DOI: 10.1002/hep.31204
Thyroid Hormones and Thyromimetics: A New Approach to Nonalcoholic Steatohepatitis?
Comment on
-
Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.Lancet. 2019 Nov 30;394(10213):2012-2024. doi: 10.1016/S0140-6736(19)32517-6. Epub 2019 Nov 11. Lancet. 2019. PMID: 31727409 Clinical Trial.
References
-
- Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam M, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol 2018;15:11‐20. - PubMed
-
- Guo Z, Li M, Han B, Qi X. Association of non‐alcoholic fatty liver disease with thyroid function: a systematic review and meta‐analysis. Dig Liver Dis 2018;50:1153‐1162. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical